Document is current
Any future updates will be listed below
-
Authors
Cipolletta, Edoardo https://orcid.org/0000-0002-6881-8197
Di Battista, Jacopo https://orcid.org/0000-0001-9077-9377
Di Carlo, Marco https://orcid.org/0000-0002-0906-4647
Di Matteo, Andrea https://orcid.org/0000-0003-0867-7051
Salaffi, Fausto https://orcid.org/0000-0002-5264-652X
Grassi, Walter
Filippucci, Emilio https://orcid.org/0000-0002-7251-7784
- License Information
-
More Information
Article History
Received: 13 March 2021
Accepted: 28 June 2021
First Online: 9 July 2021
Declarations
:
: The study was approved by the local Ethics Committee (<i>Comitato Etico Regione Marche -</i> id CERM: 168/2018).
: Not applicable.
: MDC has received speaking fees from AbbVie, Novartis, Pfizer, and Sanofi Aventis. FS has received speaking fees from AbbVie, AlfaWassermann, Biogen, Bristol-Myers Squibb, Novartis, and Pfizer. WG has received speaking fees from AbbVie, Celgene, Grünenthal, Pfizer, and Union Chimique Belge Pharma. EF has received speaking fees from AbbVie, Bristol-Myers Squibb, Janssen-Cilag, Novartis, Pfizer, Roche, and Union Chimique Belge Pharma. All other authors have declared no conflict of interest.
